WallStSmart

Api Group Corp (APG)vsSanofi ADR (SNY)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Sanofi ADR generates 479% more annual revenue ($47.35B vs $8.17B). SNY leads profitability with a 16.0% profit margin vs 4.0%. SNY earns a higher WallStSmart Score of 51/100 (C-).

APG

Hold

49

out of 100

Grade: D+

Growth: 8.0Profit: 5.5Value: 4.0Quality: 5.5
Piotroski: 5/9Altman Z: 1.69

SNY

Buy

51

out of 100

Grade: C-

Growth: 4.0Profit: 6.5Value: 5.3Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

APGSignificantly Overvalued (-23.3%)

Margin of Safety

-23.3%

Fair Value

$36.50

Current Price

$44.67

$8.17 premium

UndervaluedFair: $36.50Overvalued
SNYUndervalued (+25.0%)

Margin of Safety

+25.0%

Fair Value

$62.70

Current Price

$43.77

$18.93 discount

UndervaluedFair: $62.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

APG2 strengths · Avg: 9.0/10
EPS GrowthGrowth
61.4%10/10

Earnings expanding 61.4% YoY

Revenue GrowthGrowth
15.3%8/10

15.3% revenue growth

SNY4 strengths · Avg: 8.8/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Market CapQuality
$110.40B9/10

Large-cap with strong market position

Operating MarginProfitability
20.0%8/10

Strong operational efficiency at 20.0%

Free Cash FlowQuality
$1.68B8/10

Generating 1.7B in free cash flow

Areas to Watch

APG2 concerns · Avg: 3.5/10
Altman Z-ScoreHealth
1.694/10

Distress zone — elevated risk

Profit MarginProfitability
4.0%3/10

4.0% margin — thin

SNY3 concerns · Avg: 2.3/10
Return on EquityProfitability
6.6%3/10

ROE of 6.6% — below average capital efficiency

PEG RatioValuation
3.962/10

Expensive relative to growth rate

EPS GrowthGrowth
-11.7%2/10

Earnings declined 11.7%

Comparative Analysis Report

WallStSmart Research

Bull Case : APG

The strongest argument for APG centers on EPS Growth, Revenue Growth. Revenue growth of 15.3% demonstrates continued momentum.

Bull Case : SNY

The strongest argument for SNY centers on Price/Book, Market Cap, Operating Margin. Profitability is solid with margins at 16.0% and operating margin at 20.0%.

Bear Case : APG

The primary concerns for APG are Altman Z-Score, Profit Margin. Thin 4.0% margins leave little buffer for downturns.

Bear Case : SNY

The primary concerns for SNY are Return on Equity, PEG Ratio, EPS Growth.

Key Dynamics to Monitor

APG profiles as a growth stock while SNY is a mature play — different risk/reward profiles.

APG carries more volatility with a beta of 1.69 — expect wider price swings.

APG is growing revenue faster at 15.3% — sustainability is the question.

SNY generates stronger free cash flow (1.7B), providing more financial flexibility.

Bottom Line

SNY scores higher overall (51/100 vs 49/100), backed by strong 16.0% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Api Group Corp

INDUSTRIALS · ENGINEERING & CONSTRUCTION · USA

APi Group Corporation provides security, specialty and industrial services primarily in North America. The company is headquartered in New Brighton, Minnesota.

Visit Website →

Sanofi ADR

HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA

Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company is headquartered in Paris, France.

Want to dig deeper into these stocks?